Home / Import refusals / SCS-2000350-9/11/1

FDA Import Refusal SCS-2000350-9/11/1 — Gregory Pharmaceutical Holdings Inc.

Gregory Pharmaceutical Holdings Inc. — FEI 1000208638

The FDA refused shipment SCS-2000350-9/11/1 from Gregory Pharmaceutical Holdings Inc. (United States) on January 12, 2024. The refused product falls under Drugs and Biologics — POLYMYXIN B SULFATE (PEPTIDES). Cited charges: 118,3280 This firm has 3 other import refusals on record.

Refusal Details

Date
January 12, 2024
Country
United States
Product Category
Drugs and Biologics
Product Code
56FBK30 POLYMYXIN B SULFATE (PEPTIDES)
Charges
118,3280

Recent inspections

  • 1249609 (VAI Fri Sep 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1086261 (VAI Fri Apr 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 998826 (NAI Fri Oct 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 940674 (VAI Fri Aug 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 884329 (VAI Wed Jun 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • 112-9196840-6/1/1 (Fri Jan 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 112-8623277-1/2/2 (Wed Jan 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 112-8299587-7/1/1 (Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources